GSK files Form 13F: $799M in disclosed holdings

Q: What does GSK's Form 13F filed 02-12-2026 show?

It reports 15 holdings with aggregate value $799,022,938. The filing is a standard institutional holdings report signed by Victoria Whyte on 02-12-2026, summarizing positions managed by GSK plc as of the report period.

Q: How many positions did GSK (GSK) report in this 13F?

The report lists 15 information table entries. The Form 13F Information Table Entry Total equals 15, indicating the number of distinct holdings disclosed in this filing rather than transaction activity or changes.

Q: What is the total market value reported by GSK in the 13F?

The combined market value is $799,022,938. This figure appears on the Form 13F Summary Page as the Information Table Value Total, rounded to the nearest dollar and representing the aggregate value of the disclosed holdings.

Q: Who certified GSK's Form 13F filing and when was it signed?

Victoria Whyte signed as Authorised Signatory. The signature block shows Victoria Whyte, Authorised Signatory for and on behalf of GSK plc, with the filing signed in London on 02-12-2026.

Q: Does this Form 13F filing indicate GSK is the only reporting manager?

Yes. The filing lists no other included managers. The List of Other Included Managers section states NONE and the Number of Other Included Managers is shown as 0, indicating this report stands alone for the manager.

GSK plc filed a Form 13F reporting holdings.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

13F-HR

Rhea-AI Filing Summary

GSK plc filed a Form 13F reporting holdings. The filing lists 15 reported positions with a combined market value of $799,022,938. The report is signed by Victoria Whyte as Authorised Signatory and dated 02-12-2026.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does GSK's Form 13F filed 02-12-2026 show?

It reports 15 holdings with aggregate value $799,022,938. The filing is a standard institutional holdings report signed by Victoria Whyte on 02-12-2026, summarizing positions managed by GSK plc as of the report period.

How many positions did GSK (GSK) report in this 13F?

The report lists 15 information table entries. The Form 13F Information Table Entry Total equals 15, indicating the number of distinct holdings disclosed in this filing rather than transaction activity or changes.

What is the total market value reported by GSK in the 13F?

The combined market value is $799,022,938. This figure appears on the Form 13F Summary Page as the Information Table Value Total, rounded to the nearest dollar and representing the aggregate value of the disclosed holdings.

Who certified GSK's Form 13F filing and when was it signed?

Victoria Whyte signed as Authorised Signatory. The signature block shows Victoria Whyte, Authorised Signatory for and on behalf of GSK plc, with the filing signed in London on 02-12-2026.

Does this Form 13F filing indicate GSK is the only reporting manager?

Yes. The filing lists no other included managers. The List of Other Included Managers section states NONE and the Number of Other Included Managers is shown as 0, indicating this report stands alone for the manager.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 02/12/2026 - 04:29 PM

The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F COVER PAGE

OMB APPROVAL

OMB Number:			3235-0006
Estimated average burden
hours per response:			23.8

Report for the Calendar Year or Quarter Ended:

12-31-2025

Check here if Amendment		Amendment Number:
This Amendment (Check only one.):		is a restatement.
		adds new holdings entries.

Institutional Investment Manager Filing this Report:
Name:	GSK plc
Address:	79 NEW OXFORD STREET

	London, X0 WC1A 1DG
Form 13F File Number:	028-26280
CRD Number (if applicable):
SEC File Number (if applicable):

The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables, are considered integral parts of this form.

Person Signing this Report on Behalf of Reporting Manager:
Name:	Victoria Whyte
Title:	Authorised Signatory for and on behalf of GSK plc
Phone:	44-77709-42658
Signature, Place, and Date of Signing:
/s/ Victoria Whyte		London, X0	02-12-2026
[Signature]		[City, State]	[Date]

Report Type (Check only one.):
X	13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager are reported in this report.)
	13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting manager(s).)
	13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s).)

Form 13F Summary Page
	Report Summary:
	Number of Other Included Managers:	0
	Form 13F Information Table Entry Total:	15
	Form 13F Information Table Value Total:	799,022,938
		(round to nearest dollar)

List of Other Included Managers:
Provide a numbered list of the name(s) and Form 13F file number(s) of all institutional investment managers with respect to which this report is filed, other than the manager filing this report.
[If there are no entries in this list, state "NONE" and omit the column headings and list entries.]
NONE

Source: View Original Filing on SEC EDGAR